Significance of 18F-fluorocholine PET/CT positive pulmonary lesions in prostate cancer patients

Rager, Olivier; Baskin, A; Amzalag, G; Buchegger, Franz; Miralbell, Raymond; Ratib, Osman; Zilli, Thomas; Garibotto, Valentina

doi:10.3413/Nukmed-0737-15-04

Scientific article

English

Significance of 18F-fluorocholine PET/CT positive pulmonary lesions in prostate cancer patients

ContributorsRager, Olivier; Baskin, A; Amzalag, G; Buchegger, Franz; Miralbell, Raymond; Ratib, Osman; Zilli, Thomas; Garibotto, Valentina

Published inNuclear-Medizin, vol. 54, no. 5, p. 211-216

Publication date2015

Abstract

To assess the frequency and the significance of incidental pulmonary lesions with 18F-fluorocholine (18F-FCH) PET/CT in prostate cancer (PCa) patients.

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de radiologie et informatique médicale

Research groups

Citation (ISO format)

RAGER, Olivier et al. Significance of 18F-fluorocholine PET/CT positive pulmonary lesions in prostate cancer patients. In: Nuclear-Medizin, 2015, vol. 54, n° 5, p. 211–216. doi: 10.3413/Nukmed-0737-15-04

Identifiers

PID : unige:84096
DOI : 10.3413/Nukmed-0737-15-04
PMID : 26213186

Journal ISSN0029-5566

590views

0downloads

Creation11/30/2015 4:02:00 PM

First validation11/30/2015 4:02:00 PM

Update time03/15/2023 12:24:06 AM

Status update03/15/2023 12:24:06 AM

Last indexation10/31/2024 3:31:40 AM

Archive ouverte UNIGE

Significance of 18F-fluorocholine PET/CT positive pulmonary lesions in prostate cancer patients

To assess the frequency and the significance of incidental pulmonary lesions with 18F-fluorocholine (18F-FCH) PET/CT in prostate cancer (PCa) patients.

Technical informations